Vitiligo is caused by the destruction of melanocytes, the cells that produce pigment in your skin. The primary driver is an autoimmune attack: your immune system mistakenly targets and kills these pigment-producing cells, leaving behind patches of white or light skin. Around 0.5% to 1% of the global population has the condition, and while researchers now understand the core mechanism well, multiple factors work together to set it in motion.
The Immune System Attacks Pigment Cells
The central event in vitiligo is straightforward but destructive. A specific type of immune cell, called a cytotoxic T cell, infiltrates the edges of pigmented skin and kills melanocytes on contact. Research published in the Journal of Investigative Dermatology confirmed this by extracting T cells from the borders of vitiligo patches and showing they were heavily primed to recognize melanocyte proteins. When placed on normally pigmented skin samples, these T cells infiltrated the tissue and efficiently destroyed the melanocytes within it.
What makes this process so precise is that these immune cells only target melanocytes. When researchers tested the same T cells on skin that had already lost its pigment, no further damage occurred, because there were no melanocytes left to attack. This selectivity is the hallmark of an autoimmune disease: the immune system has learned to treat a normal, healthy cell type as a threat.
This autoimmune mechanism also explains why vitiligo often appears alongside other autoimmune conditions. About 15% of people with vitiligo develop thyroid disease, and roughly 20% carry thyroid-specific antibodies even without symptoms. The risk of alopecia areata, another autoimmune condition that causes hair loss, is about 2.6 times higher in people with vitiligo than in the general population. These overlapping risks suggest a shared tendency for the immune system to lose tolerance for the body’s own tissues.
Genetics Load the Gun
Vitiligo runs in families, though not in a simple, predictable pattern. Genome-wide studies have identified more than 50 genes linked to vitiligo risk, and most of them fall into two categories: genes that regulate the immune system and genes that are specific to melanocytes.
On the immune side, many of the risk genes control how T cells activate, communicate, and decide what to attack. Variants in these genes can shift the balance between immune tolerance (leaving your own cells alone) and immune aggression (targeting them). Other risk genes influence how the body responds to viruses and inflammation, suggesting that infections or inflammatory events could tip a genetically susceptible person toward developing vitiligo.
On the melanocyte side, risk genes include those responsible for producing the enzyme that drives melanin production and the receptor that responds to pigmentation-stimulating hormones. One gene encodes a protein critical to the internal structure of melanosomes, the tiny compartments inside melanocytes where pigment is made and stored. Variants in these genes may make melanocytes more visible or more vulnerable to immune detection. In other words, the very proteins that define a melanocyte’s job can become the targets the immune system locks onto.
Having risk variants doesn’t guarantee you’ll develop vitiligo. Most people who carry these genes never do. But the more variants you carry across both categories, the lower your threshold for triggering the disease when other factors come into play.
Oxidative Stress Damages Cells From Within
Before the immune system ever launches its attack, something may already be going wrong inside the skin. People with vitiligo accumulate abnormally high levels of hydrogen peroxide in their epidermis. This isn’t the diluted solution you’d use to clean a cut. The concentrations measured in vitiligo skin are high enough to damage proteins and disrupt normal cell signaling.
That excess hydrogen peroxide oxidizes key signaling molecules in the skin, including the hormones that normally stimulate melanocytes to produce pigment. Once oxidized, these hormones lose their ability to promote pigmentation. The damage is reversible in laboratory settings: when researchers neutralized the hydrogen peroxide using a specialized enzyme treatment, the signaling molecules regained their function. But in untreated skin, the oxidative environment creates a vicious cycle where melanocytes are both starved of survival signals and increasingly stressed.
Oxidative stress may also act as a bridge to the autoimmune response. Stressed or damaged melanocytes release internal proteins that the immune system can interpret as danger signals, potentially triggering the T cell attack that drives the visible loss of pigment.
Melanocytes Can Physically Detach From Skin
A less well-known contributor to vitiligo involves the physical anchoring of melanocytes within the skin. Melanocytes normally sit at the base of the epidermis, held in place by adhesion molecules that bind them to neighboring cells and the structural matrix beneath them. In vitiligo, several of these adhesion molecules are defective or reduced.
When melanocytes lose their grip, they can detach from the basal layer and drift upward through the epidermis, where they eventually die. This process, sometimes called melanocytorrhagy, is a form of programmed cell death triggered by loss of anchorage. Researchers have found that in people with active, spreading vitiligo, melanocytes adhere poorly to the structural proteins around them and show elevated markers of cell death. In people with stable vitiligo or unaffected skin, melanocytes hold on firmly.
One striking finding is that disruptions in a key adhesion protein between melanocytes and the surrounding skin cells can be detected before any visible depigmentation appears. This suggests adhesion failure may be an early event, not just a consequence of immune attack.
Physical Trauma and the Koebner Response
Many people with vitiligo notice new white patches appearing at sites of skin injury. This is called the Koebner phenomenon, and it occurs when physical damage to the skin triggers the disease process in areas that were previously unaffected. Cuts, burns, surgical wounds, insect bites, friction from tight clothing, tattoos, and even sunburns can all provoke it. The injury needs to penetrate at least through the outer and middle layers of the skin to set off this response.
The Koebner phenomenon helps explain why vitiligo patches often appear on the hands, elbows, knees, and around the waistband, all areas subject to regular friction or minor trauma. For someone whose immune system is already primed to attack melanocytes, local skin damage may release just enough cellular debris and inflammatory signals to draw T cells to the area.
Chemical Exposure as a Trigger
Certain industrial and household chemicals can trigger depigmentation that looks identical to vitiligo, and in genetically susceptible people, they may initiate the autoimmune process itself. The best-documented culprits are phenolic compounds, chemicals structurally similar to the building blocks of melanin. Because they resemble natural melanocyte molecules, the immune system may begin targeting real melanocytes after being exposed to these look-alikes.
Occupational cases have been documented in workers handling rubber products, which can contain phenolic antioxidant byproducts formed during manufacturing. One investigation found that unprocessed bulk rubber contained a known depigmenting agent as an unintended byproduct of the antioxidant synthesis process. Workers who regularly handled the material developed depigmented patches on their hands and arms. Hair dyes, adhesives, leather products, and certain cleaning agents can also contain phenolic chemicals capable of triggering depigmentation in susceptible individuals.
How These Causes Work Together
Vitiligo is not a single-cause disease. The current understanding is that genetic susceptibility creates a foundation, oxidative stress and adhesion defects weaken melanocytes from within, and then an environmental trigger (physical trauma, chemical exposure, severe sunburn, or psychological stress) tips the balance toward an active immune attack. Once cytotoxic T cells begin destroying melanocytes, the process can sustain itself: dying melanocytes release more proteins for the immune system to react to, spreading the attack to new areas of skin.
This layered model explains why vitiligo is so unpredictable. Some people develop a single small patch that never spreads. Others experience rapid, widespread depigmentation. The difference likely comes down to how many contributing factors are active at once, how strongly the immune response escalates, and whether the triggers that started the process continue or resolve.